Literature DB >> 22710876

The Pseudomonas aeruginosa PhoP-PhoQ two-component regulatory system is induced upon interaction with epithelial cells and controls cytotoxicity and inflammation.

Shaan L Gellatly1, Brittany Needham, Laurence Madera, M Stephen Trent, Robert E W Hancock.   

Abstract

The adaptation of Pseudomonas aeruginosa to its environment, including the host, is tightly controlled by its network of regulatory systems. The two-component regulatory system PhoPQ has been shown to play a role in the virulence and polymyxin resistance of P. aeruginosa as well as several other Gram-negative species. Dysregulation of this system has been demonstrated in clinical isolates, yet how it affects virulence of P. aeruginosa is unknown. To investigate this, an assay was used whereby bacteria were cocultured with human bronchial epithelial cells. The interaction of wild-type (WT) bacteria that had adhered to epithelial cells led to a large upregulation of the expression of the oprH-phoP-phoQ operon and its target, the arn lipopolysaccharide (LPS) modification operon, in a PhoQ-dependent manner, compared to cells in the supernatant that had failed to adhere. Relative to the wild type, a phoQ mutant cocultured on epithelial cells produced less secreted protease and lipase and, like the phoQ mutant, piv, lipH, and lasB mutants demonstrated reduced cytotoxicity toward epithelial cells. Mutation in phoQ also resulted in alterations to lipid A and to increased inflammatory LPS. These data indicate that mutation of phoQ results in a phenotype that is similar to the less virulent but more inflammatory phenotype of clinical strains isolated from chronic-stage cystic fibrosis lung infections.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22710876      PMCID: PMC3418734          DOI: 10.1128/IAI.00382-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  65 in total

1.  Microbial ecology and adaptation in cystic fibrosis airways.

Authors:  Lei Yang; Lars Jelsbak; Søren Molin
Journal:  Environ Microbiol       Date:  2011-03-24       Impact factor: 5.491

2.  PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients.

Authors:  Amanda K Miller; Mark K Brannon; Laurel Stevens; Helle Krogh Johansen; Sara E Selgrade; Samuel I Miller; Niels Høiby; Samuel M Moskowitz
Journal:  Antimicrob Agents Chemother       Date:  2011-10-03       Impact factor: 5.191

3.  Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa.

Authors:  R K Ernst; E C Yi; L Guo; K B Lim; J L Burns; M Hackett; S I Miller
Journal:  Science       Date:  1999-11-19       Impact factor: 47.728

4.  PhoP-PhoQ homologues in Pseudomonas aeruginosa regulate expression of the outer-membrane protein OprH and polymyxin B resistance.

Authors:  E L Macfarlane; A Kwasnicka; M M Ochs; R E Hancock
Journal:  Mol Microbiol       Date:  1999-10       Impact factor: 3.501

5.  The response regulator PhoP is important for survival under conditions of macrophage-induced stress and virulence in Yersinia pestis.

Authors:  P C Oyston; N Dorrell; K Williams; S R Li; M Green; R W Titball; B W Wren
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

6.  The role of the phoPQ operon in the pathogenesis of the fully virulent CO92 strain of Yersinia pestis and the IP32953 strain of Yersinia pseudotuberculosis.

Authors:  Joel Bozue; Sherry Mou; Krishna L Moody; Christopher K Cote; Sylvia Trevino; David Fritz; Patricia Worsham
Journal:  Microb Pathog       Date:  2011-02-12       Impact factor: 3.738

7.  Unique lipid a modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis.

Authors:  Robert K Ernst; Samuel M Moskowitz; Julia C Emerson; Gretchen M Kraig; Kristin N Adams; Megan D Harvey; Bonnie Ramsey; David P Speert; Jane L Burns; Samuel I Miller
Journal:  J Infect Dis       Date:  2007-08-22       Impact factor: 5.226

8.  Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants.

Authors:  Oana Ciofu; Lotte F Mandsberg; Thomas Bjarnsholt; Tina Wassermann; Niels Høiby
Journal:  Microbiology       Date:  2009-12-17       Impact factor: 2.777

9.  Phenotypic and genome-wide analysis of an antibiotic-resistant small colony variant (SCV) of Pseudomonas aeruginosa.

Authors:  Qing Wei; Saeed Tarighi; Andreas Dötsch; Susanne Häussler; Mathias Müsken; Victoria J Wright; Miguel Cámara; Paul Williams; Steven Haenen; Bart Boerjan; Annelies Bogaerts; Evy Vierstraete; Peter Verleyen; Liliane Schoofs; Ronnie Willaert; Valérie N De Groote; Jan Michiels; Ken Vercammen; Aurélie Crabbé; Pierre Cornelis
Journal:  PLoS One       Date:  2011-12-15       Impact factor: 3.240

10.  Pseudomonas aeruginosa elastase provides an escape from phagocytosis by degrading the pulmonary surfactant protein-A.

Authors:  Zhizhou Kuang; Yonghua Hao; Brent E Walling; Jayme L Jeffries; Dennis E Ohman; Gee W Lau
Journal:  PLoS One       Date:  2011-11-01       Impact factor: 3.240

View more
  26 in total

1.  Metabolomics Study of the Synergistic Killing of Polymyxin B in Combination with Amikacin against Polymyxin-Susceptible and -Resistant Pseudomonas aeruginosa.

Authors:  Maytham Hussein; Mei-Ling Han; Yan Zhu; Qi Zhou; Yu-Wei Lin; Robert E W Hancock; Daniel Hoyer; Darren J Creek; Jian Li; Tony Velkov
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

2.  Bordetella pertussis lipid A glucosamine modification confers resistance to cationic antimicrobial peptides and increases resistance to outer membrane perturbation.

Authors:  Nita R Shah; Robert E W Hancock; Rachel C Fernandez
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

3.  A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.

Authors:  Shawn M Zimmerman; Audrey-Ann J Lafontaine; Carmen M Herrera; Amanda B Mclean; M Stephen Trent
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

4.  The regulation of antimicrobial peptide resistance in the transition to insect symbiosis.

Authors:  Adam L Clayton; Shinichiro Enomoto; Yinghua Su; Colin Dale
Journal:  Mol Microbiol       Date:  2017-01-17       Impact factor: 3.501

5.  Mechanisms of Increased Resistance to Chlorhexidine and Cross-Resistance to Colistin following Exposure of Klebsiella pneumoniae Clinical Isolates to Chlorhexidine.

Authors:  Matthew E Wand; Lucy J Bock; Laura C Bonney; J Mark Sutton
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

Review 6.  The immunology of host defence peptides: beyond antimicrobial activity.

Authors:  Robert E W Hancock; Evan F Haney; Erin E Gill
Journal:  Nat Rev Immunol       Date:  2016-04-18       Impact factor: 53.106

7.  Molecular Interactions of Lipopolysaccharide with an Outer Membrane Protein from Pseudomonas aeruginosa Probed by Solution NMR.

Authors:  Iga Kucharska; Binyong Liang; Nicholas Ursini; Lukas K Tamm
Journal:  Biochemistry       Date:  2016-08-31       Impact factor: 3.162

8.  Virulence adaptations of Pseudomonas aeruginosa isolated from patients with non-cystic fibrosis bronchiectasis.

Authors:  Taylor E Woo; Jessica Duong; Nicole M Jervis; Harvey R Rabin; Michael D Parkins; Douglas G Storey
Journal:  Microbiology       Date:  2016-12       Impact factor: 2.777

9.  Refinement of OprH-LPS Interactions by Molecular Simulations.

Authors:  Joonseong Lee; Dhilon S Patel; Iga Kucharska; Lukas K Tamm; Wonpil Im
Journal:  Biophys J       Date:  2017-01-24       Impact factor: 4.033

10.  Probing the sRNA regulatory landscape of P. aeruginosa: post-transcriptional control of determinants of pathogenicity and antibiotic susceptibility.

Authors:  Yi-Fan Zhang; Kook Han; Courtney E Chandler; Brian Tjaden; Robert K Ernst; Stephen Lory
Journal:  Mol Microbiol       Date:  2017-11-02       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.